Assessment of MUcociLiary Transport timE in CRSwNP Patients in Treatment With Dupilumab: AMULET Study

Int Forum Allergy Rhinol. 2026 Jun 5. doi: 10.1002/alr.70195. Online ahead of print.

Authors

Affiliations

¹ Department of Otorhinolaryngology and Head and Neck Surgery, Azienda Ospedaliero-Universitaria Senese, Siena, Italy.
² Department of Otorhinolaryngology and Head and Neck Surgery, Bellaria Hospital, AUSL Bologna, Bologna, Italy.
³ Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy.

PMID: 42244491
DOI: 10.1002/alr.70195

No abstract available

Keywords: biological treatment; chronic rhinosinusitis; nasal mucosa; nasal polyps; type‐2 inflammation.

Grants and funding

SGZ-2022-13785/Sanofi Regeneron